Evidence map›Paper›PMID 36658273›Full record

ArticleEsophagus : official journal of the Japan Esophageal Society2023

Correction: Implication of changes in PD-L1 expression during neoadjuvant chemotherapy with docetaxel, cisplatin, and 5-fluorouracil (DCF) regimen in esophageal squamous cell carcinoma.

Seiichiro Mitani, Hisato Kawakami, Osamu Shiraishi, Hiroaki Kanemura, Shinichiro Suzuki, Koji Haratani, Hidetoshi Hayashi, Kimio Yonesaka, Yasutaka Chiba, Takushi Yasuda and 1 more

Open access · bronzeAbstract readPublished Erratum
PubMed Publisher
In one paragraph

Article in Esophagus : official journal of the Japan Esophageal Society, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 99% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Seiichiro MitaniDepartment of Medical Oncology, Faculty of Medicine, Kindai University, 377-2 Onohigashi, Osaka-Sayama, Osaka, 589-8511, Japan.
Hisato KawakamiDepartment of Medical Oncology, Faculty of Medicine, Kindai University, 377-2 Onohigashi, Osaka-Sayama, Osaka, 589-8511, Japan. kawakami_h@med.kindai.ac.jp.ORCID http://orcid.org/0000-0002-3280-4850
Osamu ShiraishiDepartment of Surgery, Faculty of Medicine, Kindai University, Osaka-Sayama, Japan.
Hiroaki KanemuraDepartment of Medical Oncology, Faculty of Medicine, Kindai University, 377-2 Onohigashi, Osaka-Sayama, Osaka, 589-8511, Japan.
Shinichiro SuzukiDepartment of Medical Oncology, Faculty of Medicine, Kindai University, 377-2 Onohigashi, Osaka-Sayama, Osaka, 589-8511, Japan.
Koji HarataniDepartment of Medical Oncology, Faculty of Medicine, Kindai University, 377-2 Onohigashi, Osaka-Sayama, Osaka, 589-8511, Japan.
Hidetoshi HayashiDepartment of Medical Oncology, Faculty of Medicine, Kindai University, 377-2 Onohigashi, Osaka-Sayama, Osaka, 589-8511, Japan.
Kimio YonesakaDepartment of Medical Oncology, Faculty of Medicine, Kindai University, 377-2 Onohigashi, Osaka-Sayama, Osaka, 589-8511, Japan.
Yasutaka ChibaClinical Research Center, Kindai University Hospital, Osaka-Sayama, Japan.
Takushi YasudaDepartment of Surgery, Faculty of Medicine, Kindai University, Osaka-Sayama, Japan.
Kazuhiko NakagawaDepartment of Medical Oncology, Faculty of Medicine, Kindai University, 377-2 Onohigashi, Osaka-Sayama, Osaka, 589-8511, Japan.
Kindai University · JPKindai University Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID36658273
OpenAlexW4317520014

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.